ADAM17 and cancer: In sum, our data unveil that the interaction of cellular integrin α5β1 with ADAM17 exposed on the surface of exosomes is negatively regulated by CD9 and plays a role in EV adhesion and uptake by CRC cancer cells and PMCs, suggesting that these molecules could be relevant therapeutic targets to inhibit CRC peritoneal carcinomatosis.